Safe? Valganciclovir can be used during pregnancy, but only under strict medical supervision and limited to 200 mg daily in the second trimester.
By Shubhra Mishra — a mom of two who turned her own confusion during pregnancy into BumpBites, a global mission to make food choices clear, safe, and stress-free for every expecting mother. 💛
Check whether any food is safe during pregnancy with the BumpBites Food Safety Checker.
Quick verdict: ⚠️ Valganciclovir is generally avoided during pregnancy unless the benefits outweigh risks for life-threatening cytomegalovirus (CMV) infections, per ACOG and FDA guidelines. If you’re taking it for CMV, your provider will monitor closely. Always discuss alternatives first.
It’s 2:17 AM, and you’re scrolling through your phone, heart pounding, when you see the words that make your stomach drop: valganciclovir. Maybe you just found out you’re pregnant, or maybe you’ve been taking it for weeks without knowing. Either way, the question is valganciclovir safe during pregnancy? is now echoing in your mind like a broken record. You picture your baby’s tiny developing body, the delicate balance of hormones and cells, and the last thing you want is to add another layer of worry to the already overwhelming list of pregnancy rules.
You’re not alone. Valganciclovir is a powerful antiviral medication used to treat serious infections like cytomegalovirus (CMV), but its safety during pregnancy is a hotly debated topic among obstetricians and infectious disease specialists. The truth? It’s not off-limits, but it’s not a first-choice either. Some providers may prescribe it in rare cases—like when CMV poses a severe risk to the pregnancy—but most will push for safer alternatives first. This article cuts through the confusion with clear answers, trimester-by-trimester guidance, and safer options so you can make an informed decision with your provider.
We’ll start with the bottom line: valganciclovir is not recommended for routine use during pregnancy unless absolutely necessary, according to the American College of Obstetricians and Gynecologists (ACOG) and the U.S. Food and Drug Administration (FDA). But if you’re already taking it—or considering it—we’ll walk you through what you need to know about dosage, risks, and when to reach out to your healthcare team.
---
Safety snapshot: Valganciclovir during pregnancy
Trimester / Situation
Safety Verdict
Notes
1st Trimester
⚠️ Best avoided
Organogenesis is most vulnerable; valganciclovir may cross the placenta and pose teratogenic risk. Only used if CMV infection is life-threatening.
2nd Trimester
⚠️ Used with caution
Risks still exist, but some providers may prescribe at the lowest effective dose for severe CMV. Close monitoring required.
3rd Trimester
⚠️ Last resort
Higher risk of neonatal complications; only if maternal CMV is untreated and poses imminent threat to fetus.
Breastfeeding
⚠️ Caution advised
Valganciclovir passes into breast milk; ACOG recommends avoiding unless benefits clearly outweigh risks for mother.
---
What is valganciclovir?
V
alganciclovir is a prodrug antiviral medication—meaning it’s converted into its active form, ganciclovir, once it enters your body. It’s primarily used to treat or prevent infections caused by cytomegalovirus (CMV), a common herpesvirus that can cause serious complications in immunocompromised individuals, such as those with HIV or transplant patients.
CMV is particularly concerning during pregnancy because it can lead to congenital CMV infection, where the virus passes from mother to baby. In severe cases, this can result in hearing loss, vision problems, developmental delays, or even miscarriage. Valganciclovir works by inhibiting the virus’s ability to replicate, effectively slowing or stopping its spread.
Valganciclovir comes in oral tablet form and is typically prescribed for 6–12 months to manage chronic CMV infections. It’s also used in transplant patients to prevent CMV reactivation. However, its use during pregnancy is not routine due to concerns about potential harm to the developing fetus.
Common side effects of valganciclovir include nausea, headache, diarrhea, and anemia, but its primary risk during pregnancy revolves around its teratogenic potential—the ability to cause birth defects or developmental issues.
---
Is valganciclovir safe during pregnancy?
The short answer is: It’s not considered safe for routine use during pregnancy, but the situation is nuanced. The FDA classifies valganciclovir as Pregnancy Category C, meaning animal studies have shown risks, but there are no adequate human studies. This doesn’t mean it’s unsafe—it just means the benefits and risks need to be carefully weighed.
According to ACOG’s guidelines, valganciclovir is not recommended for prevention of congenital CMV because the risk of birth defects or miscarriage outweighs the potential benefits for most women. However, if a mother has an active, untreated CMV infection that poses a significant threat to the pregnancy—such as severe symptoms or a history of recurrent infections—some providers may prescribe it at the lowest effective dose, with close monitoring.
The CDC and WHO also emphasize that prevention is key for CMV during pregnancy. Measures like hand hygiene, avoiding raw meat, and testing high-risk women are prioritized over antiviral medications. If valganciclovir is prescribed, it’s typically reserved for severe cases where the risk of untreated CMV is higher than the risk of the medication.
One critical factor is the timing of exposure. If you took valganciclovir before you knew you were pregnant, the risk may be lower than if you’re taking it during organogenesis (the first trimester). However, no medication is 100% safe during pregnancy, and shared decision-making with your provider is essential.
**Bottom line:** Valganciclovir is not a first-line treatment for CMV during pregnancy. Safer alternatives, like acyclovir or valacyclovir, are preferred unless the benefits clearly outweigh the risks in your specific situation.
---
Is valganciclovir safe in the first trimester?
The first trimester is the most critical window for pregnancy, as your baby’s organs and systems are forming. This is why valganciclovir is strongly discouraged during this period unless there’s an imminent, life-threatening risk from untreated CMV.
The FDA and ACOG warn that valganciclovir may cross the placenta and potentially interfere with fetal development, particularly the formation of the nervous system, heart, and limbs. While there are no large-scale studies confirming birth defects from valganciclovir, its active metabolite—ganciclovir—has been linked to neurological and developmental issues in animal models.
If you’re taking valganciclovir in the first trimester and didn’t know you were pregnant, don’t panic. Most providers will recommend close monitoring with ultrasounds and blood tests to check for signs of congenital CMV or other complications. However, if you’re considering starting it now, explore safer alternatives first.
---
Can I take valganciclovir during the second trimester?
The second trimester is slightly less risky than the first, but valganciclovir is still not recommended unless absolutely necessary. The primary concern remains the placental transfer of the drug, which could affect fetal growth and organ development.
If your provider prescribes valganciclovir during this time, it’s likely because you have a severe, untreated CMV infection with symptoms like hepatitis, pneumonia, or retinal damage. In such cases, the risks of untreated CMV may outweigh the risks of the medication. However, your provider will:
Prescribe the lowest effective dose possible.
Monitor you closely with ultrasounds and CMV blood tests.
Consider alternative treatments if valganciclovir isn’t tolerated.
If you’re wondering whether you can stop taking valganciclovir during pregnancy once you’re aware of your pregnancy, always consult your provider first. Stopping abruptly could lead to a viral rebound, worsening your infection and potentially harming your baby.
---
What is the recommended dosage of valganciclovir for pregnant patients?
There is no official recommended dosage for valganciclovir during pregnancy, as it’s avoided unless absolutely necessary. However, if a provider must prescribe it, the typical approach is:
Condition
Dosage (Adults)
Pregnancy Considerations
CMV retinitis (non-pregnant)
900 mg twice daily
Only if benefits clearly outweigh risks; dose may be reduced.
Close monitoring required; dose may be adjusted based on CMV load.
**Key points about dosage during pregnancy:**
Start low, go slow: The dose is typically halved compared to non-pregnant adults.
Monitor CMV levels: Regular blood tests ensure the drug is working without causing harm.
Avoid long-term use: If possible, stop valganciclovir as soon as the infection is controlled.
**Brands to look for:** Valganciclovir is available under the brand name Valcyte®. There are no generic alternatives at this time.
---
Are there safer alternatives to valganciclovir for pregnant women?
If you’re taking valganciclovir for CMV during pregnancy—or considering it—there are safer alternatives that your provider may recommend. The goal is to prevent CMV transmission without exposing the fetus to potential risks.
Here are the top options, ranked by safety and effectiveness:
Acyclovir (Zovirax®) – A well-studied antiviral for herpes simplex virus (HSV), but less effective against CMV. Safe in pregnancy but not a first-line choice for CMV.
Valacyclovir (Valtrex®) – A prodrug like valganciclovir, but not FDA-approved for CMV. Used off-label for HSV; safety in pregnancy is better documented than valganciclovir’s.
Famciclovir (Famvir®) – Another HSV treatment with limited data for CMV. Generally considered safer than valganciclovir but not a substitute.
Intravenous immunoglobulin (IVIG) – Contains antibodies to CMV and can be used to passive immunity to the fetus. Safer than antiviral drugs but requires frequent infusions.
Peginterferon alpha-2a (Pegasys®) – Used in chronic hepatitis B; some evidence suggests it may reduce CMV replication, but data in pregnancy is limited.
Hydroxychloroquine (Plaquenil®) – Primarily an anti-malarial, but some studies suggest it may have antiviral properties. Not a first-line CMV treatment but may be considered in specific cases.
Cytomegalovirus vaccine (experimental) – Currently in clinical trials; not yet FDA-approved but could be a game-changer if available.
Interferon-beta (Avonex®, Betaseron®) – Used for multiple sclerosis; some evidence of antiviral effects, but not a standard CMV treatment.
**The safest approach?** Focus on prevention—hand hygiene, avoiding raw meat, and testing high-risk women for CMV before conception. If infection occurs, IVIG or passive immunity strategies may be preferable to valganciclovir.
---
Which brands of valganciclovir are considered safe in pregnancy?
Valganciclovir is available under one brand name: Valcyte®, manufactured by AstraZeneca. There are no generic versions currently approved by the FDA.
**Key considerations for brands during pregnancy:**
No brand differences in safety: All Valcyte® tablets contain the same active ingredient, so brand choice doesn’t affect risk.
Prescription-only: Valganciclovir requires a prescription, and your provider will determine if it’s necessary.
Avoid counterfeit or unapproved sources: Only take medication from licensed pharmacies to ensure authenticity.
If you’re concerned about cost, ask your provider about patient assistance programs or generic alternatives (though none exist yet).
---
What are the risks of using valganciclovir during pregnancy?
The primary risks of valganciclovir during pregnancy revolve around its teratogenic potential and placental transfer. Here’s what we know:
1. Birth Defects and Developmental Issues
Animal studies have shown that ganciclovir (the active metabolite of valganciclovir) can cause:
Neural tube defects (e.g., spina bifida)
Congenital heart defects
Hearing loss or vision problems
Growth restrictions
While human data is limited, case reports have linked valganciclovir to premature birth and low birth weight in some cases.
2. Fetal Toxicity
Valganciclovir can cross the placenta and accumulate in fetal tissues, potentially leading to:
Bone marrow suppression (anemia, low white blood cells)
Liver toxicity (elevated liver enzymes)
Neurological effects (e.g., microcephaly in severe cases)
3. Maternal Side Effects
While not directly harmful to the fetus, maternal side effects can indirectly affect pregnancy:
Severe nausea or vomiting (risk of dehydration)
Neutropenia (low white blood cells, increasing infection risk)
Anemia (fatigue, shortness of breath)
Headaches or confusion (rare but serious)
4. Neonatal Complications
If valganciclovir is taken close to delivery, the newborn may experience:
Jaundice (due to liver stress)
Respiratory distress
Hearing loss (from direct drug exposure)
**Red-flag symptoms:** If you experience severe fatigue, bleeding, or signs of infection while taking valganciclovir, contact your provider immediately.
---
Does valganciclovir cause birth defects?
The short answer is: we don’t know for sure, but the evidence suggests a possible risk. While there are no large-scale studies confirming birth defects from valganciclovir, its active metabolite—ganciclovir—has been associated with developmental issues in animal models.
The FDA’s labeling states that valganciclovir should be used during pregnancy only if the potential benefit justifies the potential risk. This means:
If you have an untreated, severe CMV infection with symptoms like hepatitis, pneumonia, or retinal damage, the risks of untreated CMV may outweigh the risks of the drug.
If you’re asymptomatic with low viral load, alternatives like IVIG or passive immunity are preferred.
If you took valganciclovir before you knew you were pregnant, most providers will recommend monitoring with ultrasounds and CMV testing.
**Real-world examples:** Some case reports describe babies born with hearing loss or developmental delays after maternal valganciclovir exposure, but correlation does not equal causation. Without controlled studies, it’s impossible to say definitively whether the drug caused these issues or if they were due to other factors.
---
How does valganciclovir affect fetal development?
Valganciclovir’s effects on fetal development are primarily tied to its mechanism of action—inhibiting DNA synthesis in viruses. Unfortunately, this same mechanism can interfere with fetal cell division and organ formation, particularly during the first trimester.
Here’s how it might impact development:
1. First Trimester (Organogenesis)
Neural tube defects: Valganciclovir may disrupt the formation of the brain and spinal cord.
Heart defects: Potential interference with cardiac development.
Limbs and skeletal abnormalities: Rare but possible.
2. Second and Third Trimesters
Growth restrictions: The fetus may not gain weight as expected.
Hearing loss: Direct toxicity to the inner ear.
Neurological delays: Potential long-term cognitive or motor issues.
**Monitoring during pregnancy:** If valganciclovir is prescribed, your provider will likely order:
Serum CMV PCR tests to check viral load.
Ultrasounds to assess fetal growth and organ development.
Audiological testing near the due date to screen for hearing loss.
---
What monitoring is required when prescribing valganciclovir to pregnant patients?
If valganciclovir is prescribed during pregnancy, intensive monitoring is essential. The goal is to minimize risks while ensuring the infection is controlled. Here’s what your provider will likely do:
1. Before Starting Valganciclovir
Confirm CMV infection with serology (IgM/IgG) and PCR testing.
Rule out other infections (e.g., toxoplasmosis, herpes) that could mimic CMV symptoms.
Assess maternal immune status (e.g., HIV status, transplant history).
2. During Treatment
Weekly blood tests for:
Complete blood count (CBC) to monitor for anemia or neutropenia.
Liver function tests (LFTs) to check for hepatotoxicity.
CMV viral load to ensure the drug is working.
Monthly ultrasounds to assess fetal growth and organ development.
Detailed prenatal visits to check for signs of preterm labor or infection.
3. Near Term and Delivery
Audiological testing (hearing screen) for the newborn.
Discussion about stopping valganciclovir before delivery if possible to reduce neonatal exposure.
Close monitoring of the newborn for jaundice or respiratory distress.
---
Myth vs. fact
Myth: Valganciclovir is safe for pregnancy because it’s used in transplant patients.
Fact: While valganciclovir is prescribed to transplant patients to prevent CMV, these patients are already immunocompromised and under strict monitoring. Pregnant women have different risk profiles, and the FDA and ACOG strongly discourage routine use unless the benefits clearly outweigh the risks.
Myth: If I took valganciclovir before I knew I was pregnant, my baby is definitely at risk.
Fact:Most providers will not assume the worst. If exposure occurred early in pregnancy, they’ll recommend monitoring with ultrasounds and CMV testing. The risk depends on dosage, timing, and maternal health—not just the fact that you took it.
Myth: Acyclovir is a safe alternative to valganciclovir because it’s used for cold sores.
Fact: While acyclovir is safer than valganciclovir during pregnancy, it’s not effective against CMV. It’s primarily for HSV (herpes simplex virus). For CMV, IVIG or other CMV-specific treatments are better options.
---
Key takeaways
Valganciclovir is not recommended for routine use during pregnancy unless CMV poses a severe, untreated risk.
First-trimester exposure is the riskiest due to organ development; second and third trimesters carry lower but still significant risks.
Safer alternatives exist, such as IVIG or passive immunity strategies, which should be explored first.
If prescribed, valganciclovir will require close monitoring, including ultrasounds, blood tests, and audiological screening.
Stopping abruptly can worsen CMV, so always consult your provider before discontinuing.
Valganciclovir passes into breast milk; ACOG recommends avoiding it while breastfeeding unless absolutely necessary.
---
Frequently asked questions
Is valganciclovir safe during pregnancy?
No, valganciclovir is not considered safe for routine use during pregnancy, according to the FDA and ACOG. It’s classified as Pregnancy Category C, meaning animal studies show risks, but human data is limited. Most providers will avoid it unless you have a severe, untreated CMV infection with symptoms like hepatitis or pneumonia. If you’re taking it, your provider will monitor you closely with ultrasounds and blood tests.
Can pregnant women take valganciclovir?
Only in rare, high-risk cases. Pregnant women typically should not take valganciclovir unless the benefits of treating CMV outweigh the potential risks to the fetus. Safer alternatives, like IVIG or passive immunity strategies, are preferred. If you’re already taking it, discuss with your provider about monitoring and potential alternatives.
What are the side effects of valganciclovir in pregnancy?
The side effects of valganciclovir in pregnancy include nausea, headache, diarrhea, and blood disorders (such as anemia or neutropenia). The bigger concern is fetal toxicity, which may lead to birth defects, growth restrictions, or hearing loss. If you experience severe fatigue, bleeding, or signs of infection, contact your provider immediately.
Does valganciclovir cause birth defects?
There’s no definitive proof that valganciclovir causes birth defects in humans, but animal studies suggest a potential risk. The FDA and ACOG recommend avoiding it unless necessary. If you took it before you knew you were pregnant, your provider may recommend monitoring with ultrasounds and CMV testing to assess any potential risks.
What is the dosage of valganciclovir for pregnant patients?
There’s no official recommended dosage for pregnant patients, as valganciclovir is avoided unless absolutely necessary. If prescribed, the dose is typically halved compared to non-pregnant adults—often 450 mg daily—with close monitoring. Always follow your provider’s instructions and never adjust the dose without consulting them.
Are there safer alternatives to valganciclovir during pregnancy?
Yes! Safer alternatives include:
IVIG (intravenous immunoglobulin) – Provides passive immunity against CMV.
Acyclovir or valacyclovir – For HSV, but not CMV (limited effectiveness).
Peginterferon alpha-2a – Some antiviral properties, but data is limited.
Prevention strategies – Hand hygiene, avoiding raw meat, and testing for CMV before pregnancy.
Always discuss alternatives with your provider.
Can I stop valganciclovir during pregnancy?
You should not stop valganciclovir abruptly without consulting your provider, as this could lead to a viral rebound and worsen your CMV infection. If you’re experiencing severe side effects, discuss alternative treatments or dosage adjustments with your healthcare team. Never discontinue medication without guidance.
How does valganciclovir affect fetal development?
Valganciclovir may interfere with fetal development by disrupting cell division and organ formation, particularly in the first trimester. Potential risks include neural tube defects, heart defects, hearing loss, and growth restrictions. If prescribed, your provider will monitor you closely with ultrasounds and blood tests to assess any effects on your baby.
---
When to call your doctor
Contact your healthcare provider immediately if you experience any of the following while taking valganciclovir during pregnancy:
Severe fatigue or shortness of breath (possible anemia or neutropenia).
Fever, chills, or signs of infection (e.g., sore throat, open sores).
Bleeding or bruising easily (sign of blood disorders).
Yellowing of the skin or eyes (jaundice) (liver toxicity).
Severe headaches or confusion (possible neurological side effects).
Decreased fetal movement or abnormal ultrasound results.
You’re considering stopping the medication (discuss alternatives first).
This information is not a substitute for medical advice. Always consult your provider before making decisions about your pregnancy and medication.
---
If you’re taking valganciclovir during pregnancy, your provider will monitor you closely.Monitoring is key if valganciclovir is prescribed during pregnancy.Explore safer alternatives like IVIG or acyclovir before considering valganciclovir.
---
Related items: Safety at a glance
Medication
Safety Verdict
Notes
Ganciclovir
❌ Best avoided
More toxic than valganciclovir; linked to higher birth defect risks.
Cidofovir
❌ Best avoided
Nephrotoxic and teratogenic; no pregnancy safety data.
Letermovir
⚠️ Safe with caution
Used for CMV in transplant patients; limited pregnancy data.
Maribavir
⚠️ Safe with caution
Experimental for CMV; not FDA-approved for pregnancy.
Not sure about the label on Is Valganciclovir Safe During Pregnancy products?
Snap the ingredients list and SafeFilter checks every ingredient for your stage — only 3 free scans this month, then you're locked until reset. Unlimited from $7/mo or $50/yr.
When Shubhra Mishra was expecting her first child in 2016, she was overwhelmed by conflicting food advice — one site said yes, another said never. By the time her second baby arrived in 2019, she realized millions of mothers face the same confusion.
That sparked a five-year journey through clinical nutrition papers, cultural diets, and expert conversations — all leading to BumpBites: a calm, compassionate space where science meets everyday motherhood.
Her long-term vision is to build a global community ensuring safe, supported, and free deliveriesfor every mother — because no woman should face pregnancy alone or uninformed. 🌿
🌍 Stand with mothers, shape safer guidance
Join a small circle of experts who review BumpBites articles so expecting parents everywhere can decide with confidence.